• Next Generation Health Kiosks incorporating a number of current innovative non-intrusive screening medical devices which can assist in the early detection of risk factors and symptoms of non-communicable diseases (NCD’s) including obesity, cardio-vascular disease, diabetes and cancers.
    • Diagnose and screening of NCDs
    • Incorporate innovative non-intrusive screening devices
    • Access health screening confidentially/accessibly
    • Early detection of risk factors and symptoms
  • Mobile Healthcare Units to service the gap in healthcare facility provision also offering customized diagnostic services

AboutBackground

The global burden and threat of Non-Communicable Diseases (NCDs) constitute a major challenge for development in the twenty-first century, one that undermines social and economic development throughout the world. NCDs and obesity are major contributors to the overall burden of disease (also reducing life expectancy) and associated with high medical costs due to their related diseases.

Next Generation Health Kiosks

Currently there are a number of interactive and self-service health kiosks on the market which provide the user with predominantly free and convenient access to healthcare. We are working with partners to take these one step further and our kiosks incorporate a number of current innovative non-intrusive screening medical devices which can assist in the early detection of risk factors and symptoms of non-communicable diseases (NCD’s) including obesity, cardio-vascular disease, diabetes and cancers.

  • Diagnose and screening of NCDs
  • Incorporate innovative non-intrusive screening devices
  • Access health screening confidentially/accessibly
  • Early detection of risk factors and symptoms

From a clinical point of view it has been accepted for a long time that the foremost common vital signs are blood pressure, respiratory rate, pulse and temperature.  Additional vital signs are considered to be oxygen saturation and blood glucose concentration.  To date, no healthcare kiosk has come anywhere near incorporating these vital signs. 

The ‘Next Generation Healthcare Kiosks” go one step further and incorporate a number of current innovative non-intrusive screening medical devices such as an AF Screening finger-clip sensor, spirometer, glucometer, oximeter etc.. The kiosks offer the opportunity for members of the public to access health screening in a completely confidential and accessible manner and the use of these non-invasive tools can assist in the early detection of risk factors and symptoms of NCD’s including obesity, cardio-vascular disease, diabetes and cancers.

The kiosks present a number of opportunities to make significant health efficiency savings by acting as a high impact essential NCD and obesity intervention that can be delivered through primary and secondary healthcare approaches to strengthen early detection and timely treatment (WHO, 2011).

Improvements in Diabetic Foot Care

AboutBackground

The overall global prevalence of type 2 diabetes is rising steadily. Over 366 million people worldwide have diabetes (IDF, 2011).

Foot problems can affect anyone who has diabetes. Around one in twenty people with diabetes will develop a foot ulcer in one year. More than one in ten foot ulcers result in the amputation of a foot or a leg. According to the World Health Organisation, “Diabetes is the most common cause of non-traumatic amputation of the lower limb”.

The diabetic foot condition develops from a combination of causes including poor circulation and neuropathy. Due to insensitivity or a loss of ability to feel pain, they can develop minor cuts, scrapes, blisters or pressure sores without being aware.

A product (a foot liner) has been specially designed for the treatment and prevention of all skin conditions associated with diabetic foot problems.

The foot liner made from a special fabric “Meryl” to which is added micro capsules containing glycoprotein. The unique Meryl fabric is soft and smooth and attracts the glycoprotein into the yarn which is then slowly released into the skin of the foot, delivering continuous transdermal treatment. The glycoprotein has a strong hydrating and nourishing effect repairing the skin, by stimulating dermal fibroblast growth, and also helping to heal minor superficial ulcers.

Benefits

Mobile Healthcare

Opportunity to establish Mobile Healthcare Units to service the gap in healthcare facility provision. These are Mobile Healthcare Units with equipment, Base Station Facilities – parking; replenishment, maintenance and Administrative and Paramedical Teams support.

Uses Include:-

Fourth Pillar in Cancer Treatment

History

BIOLIV A-3 Bioartificial Liver Machine

Function:-

Bioliv A3 – Issues Patent:-

Peoples’ Republic of China National Patent Office
Patent No. ZL01115670.8
Name of Invention:
Hybrid Bio-Artificial  Liver Support System
Date of Filing:
April 28, 2001
Applicant:
Cell Biotech Limited
Inventor:
Yi-long Xu
Date of Issuance:
December 8, 2004